| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | Phase II | rekrutiert |
| A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lastin | Phase II | rekrutiert |
| A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Pa | Phase II | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of | Phase II | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosi | Phase I | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermati | Phase II | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With | Phase IV | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis | Phase I / Phase II | rekrutiert |
| A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase I | rekrutiert |
| A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps | Phase III | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Phase III | rekrutiert |
| A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis | Phase I / Phase II | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Phase III | rekrutiert |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PA | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclero | Phase II | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hosp | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Co | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilim | Phase I / Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontro | Phase III | rekrutiert |
| A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chroni | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderat | Phase III | rekrutiert |
| A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis | — | rekrutiert |
| A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adu | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Phase III | rekrutiert |
| A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in P | Phase I / Phase II | rekrutiert |
| A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase I | rekrutiert |
| A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalid | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standi | ohne Phasenangabe | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psor | — | rekrutiert |
| An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Pa | Phase II | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Atypical Hemolytic-Uremic Syndrome (aHUS) Registry | — | rekrutiert |
| AutoInflammatory Disease Alliance Registry (AIDA) | — | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | ohne Phasenangabe | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| CRP Apheresis in STEMI | ohne Phasenangabe | rekrutiert |
| Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in No | ohne Phasenangabe | rekrutiert |
| Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phas | — | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients | Phase III | rekrutiert |
| Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refrac | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration | ohne Phasenangabe | rekrutiert |
| ContraBand™: Safety & Feasibility Study (RM-20-01) | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | — | rekrutiert |
| Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmon | Phase III | rekrutiert |
| Dermatitis During Adjuvant Irradiation for BREAst Cancer: | ohne Phasenangabe | rekrutiert |
| Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Saf | Phase III | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic | — | rekrutiert |
| ELEVATE-HFpEF Clinical Study | ohne Phasenangabe | rekrutiert |
| EURO-STIM Registry | — | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR | — | rekrutiert |
| Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With | Phase III | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therap | Phase III | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Pa | Phase II / Phase III | rekrutiert |
| Follitropin Delta in Long GnRH-agonist Protocol | — | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment | — | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improvement of Quality of Life by Cannabinoids in Oncologic Patients | Phase II | rekrutiert |
| Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs | — | rekrutiert |
| Intermittent Fasting to Improve Insulin Secretion | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genita | — | rekrutiert |
| Interventional Structural Registry - LuEbeck | — | rekrutiert |
| Isatuximab in Combination With Novel Agents in RRMM - Master Protocol | Phase I / Phase II | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Ch | ohne Phasenangabe | rekrutiert |
| Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator | — | rekrutiert |
| Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis | ohne Phasenangabe | rekrutiert |
| Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Follo | — | rekrutiert |
| MEthods for LOcalization of Different Types of Breast Lesions | — | rekrutiert |
| MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry | — | rekrutiert |
| MacuTherm Performance Study in Patients With iAMD | ohne Phasenangabe | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma | — | rekrutiert |
| Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Di | — | rekrutiert |
| Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry | — | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Optimizing Reperfusion to Improve Outcomes and Neurologic Function | Phase II / Phase III | rekrutiert |
| PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS | Phase II | rekrutiert |
| PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Pediatric Arm of DZL All Age Asthma Cohort | — | rekrutiert |
| Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastat | Phase III | rekrutiert |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | Phase I | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Ca | Phase III | rekrutiert |
| Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenal | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorde | — | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G | — | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Fa | — | rekrutiert |
| REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT) | — | rekrutiert |
| RFC1 Natural History Study | — | rekrutiert |
| Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add- | Phase III | rekrutiert |
| Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care A | Phase III | rekrutiert |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer | — | rekrutiert |
| Real-world Evidence on Follitropin Delta Individual Dosing | — | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neu | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Rescue of Nephrons With ALE.F02 (RENAL-F02) | Phase II | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension | Phase III | rekrutiert |
| SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of | Phase IV | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | Phase III | rekrutiert |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for P | Phase III | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biol | Phase I / Phase II | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillat | ohne Phasenangabe | rekrutiert |
| Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) | ohne Phasenangabe | rekrutiert |
| Stepcare Extended Follow-up Substudy | ohne Phasenangabe | rekrutiert |
| Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With U | ohne Phasenangabe | rekrutiert |
| Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced C | Phase III | rekrutiert |
| Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent | Phase II | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | Phase III | rekrutiert |
| Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H R | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term | Phase III | rekrutiert |
| Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With A | — | rekrutiert |
| Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in | Phase III | rekrutiert |
| Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination | Phase III | rekrutiert |
| THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for t | ohne Phasenangabe | rekrutiert |
| The "Global Paradise System" Registry | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The Fourth Left Atrial Appendage Occlusion Study | ohne Phasenangabe | rekrutiert |
| The GErman Italian Spanish Takotsubo (GEIST) Registry | — | rekrutiert |
| The German ADPKD Tolvaptan Treatment Registry | — | rekrutiert |
| This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-0682 | Phase III | rekrutiert |
| This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plu | Phase III | rekrutiert |
| Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PU | ohne Phasenangabe | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Validity of ICU Clinician's Appraisal of Proportionality in CPR | — | rekrutiert |
| WATCHMAN FLX Pro European Registry | — | rekrutiert |
| WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke | ohne Phasenangabe | rekrutiert |
| Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Mar | — | rekrutiert |